Hologic Gains Expanded CE Marking for Digital Pathology System
The Genius Digital Diagnostics System is now approved for both cell and tissue specimen imaging in the European Union.
Tag: Hologic
All
Latest
All
Latest
Hologic’s Digital Cytology System Gets FDA Clearance
The cytology system combines AI with advanced volumetric imaging technology to identify pre-cancerous lesions and cervical cancer cells.
All
Latest
Hologic Launches High Volume Molecular Testing Platform
Panther Trax's broad assay menu includes tests for women’s health, sexually transmitted infections (STIs), respiratory health, COVID-19 testing, and more.
Hologic Completes Acquisition of Biotheranostics
Biotheranostics develops and markets two highly differentiated molecular diagnostic tests for breast and metastatic cancers: Breast Cancer Index and CancerType ID.
Read More
Hologic, Google Cloud Collaborating on Digital Diagnostics for Cervical Cancer
The Hologic Genius Digital Diagnostics System is expected to derive even more actionable insights from cytology slides for cytotechnologists and pathologists with Google Cloud.
Read More
Hologic to Acquire Molecular Diagnostics Company Biotheranostics
Biotheranostics is a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers.
Read More
Aptima HIV-1 Quant Dx Assay Receives Additional FDA Approval for Use as an Aid in the Diagnosis of HIV Infection
Hologic’s Aptima HIV-1 Quant Dx assay is now the first dual-claim assay for both diagnosis and viral load monitoring in the United States.
Read More
Hologic’s Genius Digital Diagnostics System for Cervical Cancer Screening Receives CE Mark
Genius Digital Diagnostics is the first digital cytology platform to combine a new artificial intelligence algorithm with advanced digital imaging to help identify precancerous lesions and cancer cells.
Read More
HHS, DOD Award Hologic $119M Contract to Expand Covid-19 Testing Capacity
This investment will enable Hologic to expand production capacity to 13 million covid-19 tests per month by January 2022.
Read More
Advancing the Diagnosis of Vaginitis
Two FDA-approved molecular testing platforms are leading to better targeted treatments for this common infection.
Read More
FDA Amends EUA for Hologic’s Aptima SARS-CoV-2 Assay
The assay is now authorized for asymptomatic individuals and symptomatic sample pooling.
Read More
HHS, DOD Invest $7.6M in Hologic to Expand Production for Covid-19 Tests
Under the contract, Hologic will expand production of custom sample collection and processing consumables for covid-19 tests.
Read More
Hologic Launches Validated Pooling Protocol for Covid-19 Testing
By testing samples from multiple individuals simultaneously, pooling may help laboratories deliver accurate molecular test results more quickly.
Read MoreIMV ServiceTrak Awards for Clinical Laboratory Instruments
The 2020 ServiceTrak Clinical Laboratory Awards are based on interviews with respondents in 2,229 clinical testing locations having 5,117 instruments.
Read More
AdvaMed Unveils National Covid-19 Testing Registry
AdvaMed has created a comprehensive, national covid-19 diagnostic supply registry to help state and federal governments in their pandemic responses.
Read More
Avero Diagnostics Now Offering Covid-19 Testing
Avero will support the diagnostic needs of hospitals, health systems, multispecialty family practices, urgent care centers, and county health departments.
Read MoreFDA Issues Emergency Use Authorizations to Hologic and LabCorp
FDA has issued emergency use authorizations to Hologic for its Panther Fusion SARS-CoV-2 assay and to LabCorp for its Covid-19 RT-PCR test.
Read MoreHologic’s Molecular Test for the Novel Coronavirus, SARS-CoV-2, Receives FDA Emergency Use Authorization
Hospital, public health, and reference laboratories can perform the test on Hologic’s Panther Fusion system, a fully automated, high-throughput molecular diagnostic platform that is widely used across the United States.
Read More